In the first half of 2026, Farmak launched 9 new products on the Ukrainian market and paid UAH 931.9 million in taxes.
Farmak continues to invest in the development of its portfolio and provide Ukrainian patients with modern medicines, medical devices, and dietary supplements. Among the new releases are an antiseptic medication; a daytime tranquilizer designed to support patients with anxiety and asthenic conditions; an injectable drug to stop life-threatening bleeding; a dermatological lotion; an antithrombotic drug; a medical device for treating vaginal fungal infections; a dietary supplement for the daily diet of people with lactose intolerance; a medication for treating clinically confirmed vitamin D deficiency in soft gelatin capsules; and a solution for injection intended for the treatment of iron deficiency anemia.
Farmak continues to make a significant contribution to the state budget. In the first half of 2026, the company paid UAH 931.9 million in taxes. In total, over the past 5.5 years, the amount of taxes paid by Farmak reached UAH 6.6 billion.
